Skip to content

Effect of calcium and vitamin B1 on the severity of menstrual distress

Comparison of the effects of calcium and vitamin B1 on the severity of menstrual distress in 18-26 year old girls residing in dormitories

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250226064862N1
Enrollment
150
Registered
2025-07-01
Start date
2024-08-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysmenorrhea. Dysmenorrhea, unspecified

Interventions

Intervention 1: Control group: Research units in the control group will receive one placebo capsule containing lactose and microcrystalline cellulose daily for two months without the active ingredient

Sponsors

Torbate-Heidaria University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 26 Years

Inclusion criteria

Inclusion criteria: Being Iranian Being single Being at most 28 years old Having symptoms of menstrual distress for at least 3 cycles in the last 6 months Having mild to moderate dysmenorrhea by Visual Analog Scale (2=VAS =8) Having regular menstrual cycle Having a normal body mass index .

Exclusion criteria

Exclusion criteria: Having symptoms of secondary dysmenorrhea Having a history of any chronic medical disease Use psychoactive drugs Having experience of using oral contraceptive pills in the previous 6 months Following a special diet Using of tobacco or alcoholic beverages Being a professional athlete

Design outcomes

Primary

MeasureTime frame
Severity of pain. Timepoint: One cycle before the intervention and one cycle after the intervention. Method of measurement: Visual Analog Scale.;Menstrual distress. Timepoint: One cycle before the intervention and one cycle after the intervention. Method of measurement: Moos Menstrual Distress Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Kabirian

Torbate-Heidaria University of Medical Sciences

Kabirianm1@gmail.com+98 51 5242 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026